Efficacy and Safety of CTx-1301 in Pediatric Subjects With ADHD: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial

Authors
Category Primary study
ConferenceJournal of the American Academy of Child & Adolescent Psychiatry
Year 2025
This article has no abstract
Epistemonikos ID: 211b045a8e11173abac7213313dc7e99ba1edc63
First added on: Oct 17, 2025